The Pharmaceutical Journal

Industry clinical trial participation in the NHS falls for fifth year in a row, says trade body

The number of people taking part in industry clinical trials in the NHS has fallen for the fifth year in a row, data ...
The Pharmaceutical Journal

‘Rapid’ ICB headcount reductions putting delivery at risk, College warns

Delivery of integrated care board (ICB) functions have not been adequately protected during a reorganisation of the bodies, ...
The Pharmaceutical Journal

Insulin pen design can lead to missed doses for people with disabilities, patient safety investigation body finds

Insulin pen devices can present challenges for people with certain disabilities, the Health Services Safety Investigations ...
The Pharmaceutical Journal

Medicines regulator to outsource some drug assessment work to private firms

The Medicines and Healthcare products Regulatory Agency (MHRA) has awarded contracts to three private companies, in what it ...
The Pharmaceutical Journal

MHRA extends approval for gene-editing therapy to patients aged five years and over

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a gene-editing treatment for severe sickle-cell ...
pharmaceutical-journal

Personalised cancer vaccine with immunotherapy cuts risk of melanoma returning by 42%, study finds

Adding a personalised messenger RNA (mRNA) cancer vaccine to pembrolizumab — an immunotherapy drug — after surgery for high-risk melanoma reduced the risk of recurrence or death by 42%, phase III ...